Skip to content

Site logo

Main menu
  • Company
    • Company overview
    • Stories
    • History
    • Environmental, Social & Governance (ESG)
      • ESG overview
      • Philanthropy
      • Merck Medical Outreach Program
      • Impact investing
      • Transparency disclosures
      • ESG resources
    • Leadership
      • Leadership overview
      • Board of directors
      • Executive team
    • Culture & values
      • Culture & values overview
      • Code of conduct & compliance
    • Diversity & inclusion
    • Policies & positions
    • Business development & licensing
    • Suppliers
      • Suppliers overview
      • Supplier registration
      • Supplier help for Ariba
  • Research
    • Research overview
    • Areas of focus
      • Oncology
      • Vaccines
      • Infectious diseases
      • Cardio-metabolic disorders
    • Pipeline
    • Discovery & development
    • R&D locations
    • Clinical trials
      • Clinical trials overview
      • Find a trial
      • Diversity in clinical trials
  • Products
    • Products list
    • Safety data sheets
    • Product patents
    • Merck authorized distributors
  • Patients
    • Patients overview
    • Patient support programs
    • Patient resources
    • Patient & treatment education
  • Careers
    • Careers
    • Search jobs
    • Our divisions
      • Research & development
      • Manufacturing & supply
      • Human Health
      • Animal Health
      • Global support functions
    • Veterans
    • Student opportunities
    • Compensation & benefits
    • How we hire
    • MSD Careers
    • Events
    • Talent community
  • Investors
    • Investors overview
    • Events & presentations
    • Financial information
      • Financial information overview
      • SEC filings
    • Stock information
    • Investor resources
      • Investor resources overview
      • Organon resources
      • Request for information
  • Media
    • Media overview
    • News releases
    • Company statements
    • Media library & contacts
    • Company fact sheet
two scientists wearing masks

Our COVID-19 efforts

Learn more
Contact us

Worldwide Countries outside of the United States and Canada.

What can we help you find?

Search for:
Environmental, Social & Governance

VIDEO: What the “great resignation” taught us about workplace culture

In this Teal Talks episode, our chief talent officer sits down with leaders from LinkedIn, Workhuman and S’well to discuss how businesses can adapt to a new era of work

November 29, 2022

Share this article

Teal Talks episode 7 featured image
Assets / Buttons / UI / Play Button / Large clear hover
youtube
https://www.youtube.com/watch?v=MGy_YNhsRCQ
:

The global workforce is going through a significant transformation. In 2021, an unprecedented number of workers quit their jobs. What started as an economic trend called the “great resignation” has spurred lasting workplace changes.

“It’s redefining and recalibrating the relationship between employee and employer, and more specifically, what the employee feels is the employer’s responsibility to them,” said Steve Pemberton, chief human resources officer, Workhuman.

In episode seven of Teal Talks, Pemberton, along with Karin Kimbrough, chief economist at LinkedIn, and Sarah Kauss, founder of S’well, sits down with Carl Segerstrom, chief talent officer, Merck, to discuss the ongoing changes in the workplace and how businesses can continue to support the growth and development of their employees.

Why are workers quitting their jobs and where are they going?

A Pew Research Center survey found that low pay, a lack of opportunities for advancement and feeling disrespected at work were the top reasons Americans quit their jobs in 2021.

A desire to work from home in remote jobs is also driving some of the turnover in the labor market, Kimbrough said.

“Nearly half of all applicants on our platform apply for at least one remote role. And this is up from an infinitesimally small number pre-pandemic,” said Kimbrough. “So, one thing everyone is looking for is that flexibility, and a lot of that comes through remote or hybrid opportunities.”

Finding purpose at work

Research has shown that employees want purpose in their professional lives that merges with their personal values.

In a recent survey, more than half of U.S. employees said they’d be willing to take a pay cut to work at a company that shares their values.

Kauss, whose company was founded with a mission to rid the world of single-use plastics, has seen the benefits of this purpose-led mindset.

“I was very surprised by the caliber of employees that were choosing to come to a smaller startup like S’well because of our purpose,” Kauss said.

What is “quiet quitting”?

Quiet quitting, the popular term that gained global attention through a viral TikTok video, is when employees stop going above and beyond in their jobs and do the bare minimum. Some experts say quiet quitting is a residual effect of the COVID-19 pandemic, burnout and the “great resignation” because it helped make employees feel empowered to take control of their work-life balance. 

“I think what’s indicative is whether or not employers are going to meet humans halfway in their recalibration of what work looks like, how it’s done, where it’s done, and with whom it’s done.”

  • Steve Pemberton

Although many believe the choice of leaving a company may be in the hands of employees during the “great resignation”, Kimbrough said LinkedIn data is starting to show a hiring slowdown and an increase in the mention of “layoff” in their feed.

“To some, quiet quitting may mean getting the basic job done, but in these uncertain economic times, quiet quitting can mean lower productivity for the whole company, and it could push employers to let workers go,” she said.

The “great resignation’s” silver lining

We have arguably seen some of the largest disruptions to the workforce and workplace in decades, but positive developments can be found. “I think the most positive thing that has come out of this time is the increasing emphasis on social issues and how important individuals are to leading great teams and to making positive change in the world,” said Kauss.

Discover more stories

Pride, pediatrics and parenting

New podcast: Meet the dealmakers 

Safeguarding the environment through green chemistry

View all stories

Explore more in

Corporate responsibility
Workplace

Related links

related content image #1

Our culture and values

It all comes back to saving and improving lives

related content image #2

Diversity & inclusion

Our workforce represents the people we serve

related content image #3

Environmental, Social & Governance (ESG)

Supporting society, people and communities around the world is fundamental to our long-term success

Connect with us on social

social icon social icon social icon social icon social icon
  • MerckHelps
    Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients
  • Merck Access Program
    Information about insurance coverage and financial assistance options for eligible patients
  • Clinical trials
    Learn about our clinical trials and find available studies
  • Merck Manuals
    Medical information source covering thousands of topics in all fields of medicine
  • Environmental, Social & Governance (ESG) Report
    Reporting on our commitment to operating responsibly to benefit society
  • Merck for Mothers
    An initiative to create a world where no woman has to die giving life
  • Merck Animal Health
    The global animal health business unit of Merck
  • Health Plan - Transparency in Coverage
    In compliance with the Consolidated Appropriations Act, learn more about our health plan's pricing information.
  • Forward-looking statement
  • Cookie policy
  • Privacy
  • Transparency disclosure
  • Terms of use
  • Accessibility
  • Sitemap
Copyright © 2023 Merck & Co., Inc., Rahway, NJ USA, and its affiliates. All rights reserved. | This site is intended only for residents of the United States and Canada.
Accessibility icon View Privacy Shield Verification Status View APEC CBPR Privacy Certification Status

Forward-looking statement of Merck & Co., Inc., Rahway, N.J., USA

This website of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2022 and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

No Duty to Update
The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept

You are leaving Merck.com

Continue

Welcome to Merck.com

By continuing, you will be directed to a site intended only for residents of the United States and Canada. We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co Inc, Rahway, NJ USA.

Continue